Walleye Capital
NPCE icon

Walleye Capital’s Neuropace NPCE Stock Holding History

Walleye Capital’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-228,847
Closed -$3.53M – 4780
2025
Q4 		$3.53M Buy
228,847
+177,375
+345% +$2.37M 0.01% 1414
2025
Q3 		$531K Buy
51,472
+18,643
+57% +$176K ﹤0.01% 2558
2025
Q2 		$366K Sell
32,829
-84,707
-72% -$1.06M ﹤0.01% 2909
2025
Q1 		$1.44M Buy
117,536
+88,989
+312% +$1.11M 0.01% 1684
2024
Q4 		$319K Buy
+28,547
New +$248K ﹤0.01% 3368
2024
Q2 		– Sell
-19,698
Closed -$260K – 5858
2024
Q1 		$260K Buy
19,698
+5,378
+38% +$76.7K ﹤0.01% 3776
2023
Q4 		$148K Buy
+14,320
New +$114K ﹤0.01% 3846

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Walleye Capital's NPCE Position: Q1 2026 in Review

Walleye Capital sold out of Neuropace (NPCE) in Q1 2026, closing a stake of 228,847 shares — an estimated $3.53M sold.

Walleye Capital first reported a position in NPCE in Q4 2023 and held it in 7 quarters. The position peaked at $3.53M in Q4 2025. 113 funds tracked by Wall St. Rank hold NPCE as of Q1 2026.

  • Walleye Capital reported no remaining Neuropace position as of Q1 2026 after selling out during the quarter.
  • Walleye Capital sold 228,847 Neuropace shares in Q1 2026, an estimated $3.53M.
  • Walleye Capital first reported a position in Neuropace in Q4 2023 and held it in 7 quarters.
  • Walleye Capital's Neuropace position peaked at $3.53M in Q4 2025.
  • 113 funds tracked by Wall St. Rank held Neuropace as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.